Extrapulmonary Tuberculosis

This handout provides general information on extrapulmonary TB. Topics covered include symptoms of extrapulmonary TB, how to keep friends and family safe, and how extrapulmonary TB is treated.
This handout provides general information on extrapulmonary TB. Topics covered include symptoms of extrapulmonary TB, how to keep friends and family safe, and how extrapulmonary TB is treated.
This handout provides general information on extrapulmonary TB. Topics covered include symptoms of extrapulmonary TB, how to keep friends and family safe, and how extrapulmonary TB is treated.
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated...
This handout contains information for patients that are prescribed the 3HP regimen for the treatment of latent TB infection. The 3HP regimen is a 3-month once weekly regimen of isoniazid and rifapentine. The handout includes space to record the patient's doctor/clinic contact information.
This introduction to TB slide set provides a basic overview of TB. The tool is intended for a general public audience.
This clinical bulletin provides information on testing for and treating latent TB information. The bulletin also includes resources for providers, resources for patients, and more!
This 90-minute webinar focuses on how anti-black racism impacts African Americans' access to care and the quality of care they receive. The webinar also includes information on specific strategies for clinicians and programs to consider to improve TB care for African American patients.
This poster displays first-line TB treatment regimens, dosing recommendations and frequency, and adverse reactions and monitoring. The poster is 17×22 inches.
The handout provides information on the similarities and differences between COVID-19 and TB, lists who is at higher risk for TB, and includes additional recommendations.
This handout describes nontuberculous mycobacteria (NTM), clinical manifestations, NTM diagnosis, treatment, and action required. The handout also includes 2019 data from the Virginia Department of Health TB Program and links to additional information.